Highlander Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-27,600
Closed -$728K 26
2021
Q4
$728K Buy
+27,600
New +$728K 0.89% 17